About COMPASS Pathways
COMPASS Pathways is a company based in London (United Kingdom) founded in 2016 by Lars Christian Wilde.. COMPASS Pathways has raised $108.55 million across 3 funding rounds from investors including RA Capital, Perceptive Advisors and Aisling Capital. The company has 166 employees as of December 31, 2024. COMPASS Pathways offers products and services including COMP360 Psilocybin and Therapist Training. COMPASS Pathways operates in a competitive market with competitors including ATAI, Beckley Psytech, MindMed, Cybin and Delix Therapeutics, among others.
- Headquarter London, United Kingdom
- Employees 166 as on 31 Dec, 2024
- Founders Lars Christian Wilde
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Compass Pathways Plc Sponsored Adr
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-155.19 M-30.49as on Dec 31, 2024
-
EBITDA
$-178.05 M-29.77as on Dec 31, 2024
-
Total Equity Funding
$108.55 M (USD)
in 3 rounds
-
Latest Funding Round
$285 M (USD), Post-IPO
Aug 16, 2023
-
Investors
RA Capital
& 16 more
-
Employee Count
166
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of COMPASS Pathways
COMPASS Pathways is a publicly listed company on the NASDAQ with ticker symbol CMPS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of COMPASS Pathways
COMPASS Pathways offers a comprehensive portfolio of products and services, including COMP360 Psilocybin and Therapist Training. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Investigational therapy for mental health disorders like depression
Program for training professionals in psilocybin therapy methods
Unlock access to complete
Unlock access to complete
Funding Insights of COMPASS Pathways
COMPASS Pathways has successfully raised a total of $108.55M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $285 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $285.0M
-
First Round
First Round
(25 Oct 2018)
- Investors Count 17
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Post-IPO - COMPASS Pathways | Valuation |
investors |
|
| Apr, 2020 | Amount | Series B - COMPASS Pathways | Valuation | Founders Fund , Able Partners | |
| Oct, 2018 | Amount | Series A - COMPASS Pathways | Valuation | Principia SGR |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in COMPASS Pathways
COMPASS Pathways has secured backing from 17 investors, including venture fund and institutional investors. Prominent investors backing the company include RA Capital, Perceptive Advisors and Aisling Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in the US
|
Founded Year | Domain | Location | |
|
Venture capital and private equity firm
|
Founded Year | Domain | Location | |
|
Investment in transformative therapeutics is managed by the firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by COMPASS Pathways
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - COMPASS Pathways
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Compass Pathways Comparisons
Competitors of COMPASS Pathways
COMPASS Pathways operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ATAI, Beckley Psytech, MindMed, Cybin and Delix Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of neurological and psychiatric disorders
|
|
| domain | founded_year | HQ Location |
Psychedelic-based therapies for brain health disorders are developed.
|
|
| domain | founded_year | HQ Location |
Psychedelic therapeutics for psychiatric disorders are developed and provided.
|
|
| domain | founded_year | HQ Location |
Non-hallucinogenic therapeutics for neurological disorders are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Compass Pathways
Frequently Asked Questions about COMPASS Pathways
When was COMPASS Pathways founded?
COMPASS Pathways was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is COMPASS Pathways located?
COMPASS Pathways is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Who is the current CEO of COMPASS Pathways?
Kabir Nath is the current CEO of COMPASS Pathways.
Is COMPASS Pathways a funded company?
COMPASS Pathways is a funded company, having raised a total of $108.55M across 3 funding rounds to date. The company's 1st funding round was a Series A of $28.55M, raised on Oct 25, 2018.
How many employees does COMPASS Pathways have?
As of Dec 31, 2024, the latest employee count at COMPASS Pathways is 166.
What does COMPASS Pathways do?
COMPASS Pathways was founded in 2016 in London, United Kingdom. Focus is placed on the biotechnology sector, where therapies for mental disorders are developed. Psilocybin-based treatments for treatment-resistant depression are advanced, with psilocybin functioning as a partial agonist at multiple serotonin receptors. Operations center on clinical research and therapeutic innovation in mental health.
Who are the top competitors of COMPASS Pathways?
COMPASS Pathways's top competitors include MindMed, Beckley Psytech and Psylo.
What products or services does COMPASS Pathways offer?
COMPASS Pathways offers COMP360 Psilocybin and Therapist Training.
Is COMPASS Pathways publicly traded?
Yes, COMPASS Pathways is publicly traded on NASDAQ under the ticker symbol CMPS.
Who are COMPASS Pathways's investors?
COMPASS Pathways has 17 investors. Key investors include RA Capital, Perceptive Advisors, Aisling Capital, Vivo Capital, and Surveyor Capital.
What is COMPASS Pathways's ticker symbol?
The ticker symbol of COMPASS Pathways is CMPS on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.